By Mark Gleeson JOHANNESBURG (Reuters) -South Africa captain Dean Elgar scored an unbeaten 46 to give his team a chance of victory over India as they chased a target of 240 to win the second test at the Wanderers. South Africa need 122 more runs to win, and level the three-match series, after closing on …
Cricket-South Africa need 122 runs to win second test with eight wickets in hand Read More »
NEW DELHI (Reuters) – India on Wednesday reported its first COVID-19 death linked to the fast-spreading Omicron variant in the western state of Rajasthan, a federal health ministry official said. Omicron cases in the country have now risen to 2,135, the official told a small group of reporters in New Delhi. (Reporting by Krishna N. …
India reports first death linked to Omicron coronavirus variant Read More »
NEW DELHI (Reuters) -India has not added Merck’s COVID-19 pill to its national treatment protocol for the disease due to known safety concerns that have restricted its use elsewhere, a senior health official told a media briefing on Wednesday. “We have to remember that this drug has major safety concerns,” Balram Bhargava, head of the …
India says safety concerns restricting use of Merck COVID pill Read More »
By Rajendra Jadhav MUMBAI (Reuters) – Indian police said on Wednesday they had arrested three people involved in an online app that shared pictures of Muslim women for a virtual “auction” in an apparent case of communal harassment. Pictures of dozens of women had been used without their consent and doctored to create an open …
Three arrested in India for online harassment of Muslim women Read More »
BENGALURU (Reuters) – India’s drug regulator on Wednesday granted approval to Bharat Biotech for conducting late-stage trials of its nasal COVID-19 vaccine to be used as a booster shot, according to a Mint report, which cited ANI. The vaccine maker submitted the late-stage trial application to the Drugs Controller General of India (DCGI) in December, …
Bharat Biotech gets approval to test nasal COVID-19 shot as booster – report Read More »
By Mark Gleeson JOHANNESBURG (Reuters) – Indian seamer Shardul Thakur pursued a simple formula for success as he took seven wickets on the second day of the second test against South Africa at the Wanderers on Tuesday. India’s fourth choice bowler destroyed the home team’s top order as he took five wickets before tea and …
Cricket-Thakur claims seven-wicket haul with simple formula Read More »
By Mark Gleeson JOHANNESBURG (Reuters) -Seamer Shardul Thakur bagged a seven-wicket haul for India on Tuesday but the second test against South Africa remained delicately poised after the second day’s play at the Wanderers. South Africa had a slender 27-run first innings advantage after being bowled out for 229 with India 85-2 in their second …
Cricket-Thakur bags seven wickets as India move into 58-run lead Read More »
By Krishna N. Das NEW DELHI (Reuters) -Authorities in India’s capital Delhi on Tuesday ordered people to stay home over coming weekends, with COVID-19 cases quadrupling in a week. Chief Minister Arvind Kejriwal, the most senior elected official in the capital’s administration, was one of the 37,379 new COVID-19 cases reported in India in the …
Delhi imposes weekend COVID curfew but election rallies continue Read More »
By Rajendra Jadhav MUMBAI (Reuters) – Indian police on Tuesday said they had made their first arrest in an investigation into an online app that shared pictures of scores of Muslim women for an “auction” in a case of apparent hatred toward the minority community. In recent days, several Indian Muslim women said on social …
Indian police make first arrest in alleged online abuse of Muslim women Read More »
BENGALURU (Reuters) -Indian drugmaker Dr Reddy’s Laboratories Ltd will launch its generic version of Merck’s antiviral COVID-19 pill, molnupiravir, and price it at 35 rupees ($0.4693) per capsule, a company spokesperson said on Tuesday. The overall cost for a patient treated with a 5-day course of 40 capsules of the generic drug, to be sold …
Dr Reddy’s to launch generic COVID-19 Merck drug at about 50 cents a pill Read More »
